Review



mercaptopurine 6 mp  (Selleck Chemicals)


Bioz Verified Symbol Selleck Chemicals is a verified supplier
Bioz Manufacturer Symbol Selleck Chemicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Selleck Chemicals mercaptopurine 6 mp
    Mercaptopurine 6 Mp, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/Brequinar/10__1158_slash_0008___5472__can___25___0043-58-4-9
    Average 93 stars, based on 29 article reviews
    mercaptopurine 6 mp - by Bioz Stars, 2026-11
    93/100 stars

    Images

    Related Articles

    other:

    Article Title: Metabolic Dependency on De Novo Pyrimidine Synthesis is a Targetable Vulnerability in Platinum Resistant Ovarian Cancer
    Article Snippet: BRQ and 6-mercaptopurine (6-MP) were purchased from Selleck Chemicals (Cat. # S6626 and #S1305), uridine (Cat. # U3003), L-glutamine-(amide-15N) (Cat. # 490024), cisplatin (Cat. # 1134357), carboplatin (Cat. # C2538), and dipyridamole (Cat. # D9766) were from Sigma-Aldrich (St. Louis, MO).

    Article Title: Systematic dissection of the metabolic-apoptotic interface in AML reveals heme biosynthesis to be a regulator of drug sensitivity
    Article Snippet: Mercaptopurine (6-MP) , Selleck Chemicals , S1305; CAS: 50–44- 2.

    Article Title: Metabolic Dependency on De Novo Pyrimidine Synthesis is a Targetable Vulnerability in Platinum Resistant Ovarian Cancer
    Article Snippet: 27 Ovarian cancer (OC) is lethal due to near universal development of resistance to platinum-based 28 chemotherapy.. Metabolic adaptations can play a pivotal role in therapy resistance.. Here, we 29 aimed to identify key metabolic pathways that regulate platinum response and represent potential 30 therapeutic targets.



    Similar Products

    86
    Macklin Inc mercaptopurine monohydrate 6 mp
    Mercaptopurine Monohydrate 6 Mp, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/6+6+mercaptopurine+monohydrate+mp/10__1016_slash_j__jelechem__2026__120053-45-0-10
    Average 86 stars, based on 1 article reviews
    mercaptopurine monohydrate 6 mp - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    MedChemExpress 6 mp
    6 Mp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/6-Mercaptopurine/pm41644072-44-0-6
    Average 94 stars, based on 1 article reviews
    6 mp - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Enamine Ltd mercaptopurine 6 mp
    Mercaptopurine 6 Mp, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/Mercaptopurine/bio_rxiv__2025__11__20__689348-224-0-8
    Average 93 stars, based on 1 article reviews
    mercaptopurine 6 mp - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Selleck Chemicals mercaptopurine 6 mp
    Mercaptopurine 6 Mp, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/Brequinar/10__1158_slash_0008___5472__can___25___0043-58-4-9
    Average 93 stars, based on 1 article reviews
    mercaptopurine 6 mp - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Selleck Chemicals vinblastine
    ( A ) The nonstructural proteins nsp8, nsp11, and nsp16 could be restored by the proteasome inhibitor MG132. HEK293T cells in 12-well plates were transfected with the plasmids of 16 nonstructural proteins (nsp1–16) encoded by SARS-CoV-2. Thirty-six hours later, the cells were treated with MG132 (10 µM) or DMSO for 12 hr before collection. The protein level was detected by immunoblotting (IB). Quantification of nsp protein levels relative to the control protein is shown. Data are representative of three independent experiments and shown as average ± SD (n=3). Significance was determined by a two-tailed t-test: *p<0.05; **p<0.01; ***p<0.001. ( B ) Proteasomal inhibitors but no other inhibitors stabilized nsp16 protein. HEK293T cells transfected with the nsp16-Flag expression vector were treated with dimethyl sulfoxide (DMSO), MG132 (10 µM), Bortezomib (10 µM), Carfilzomib (10 µM), Bafilomycin A1 (5 µM), <t>Vinblastine</t> (2.5 µM), or NH 4 Cl (2.5 µM) for 12 hr prior to harvest. The cell lysates were analyzed by anti-Flag antibody. ( C, D ) The half-life of nsp16 was prolonged by the proteasome inhibitor MG132. (C) HEK293T cells were transfected with the nsp16-Flag-expressing plasmids. 12 hr later, the cells were treated with DMSO or MG132 (10 µM) for 12 hr, then 50 µg/ml cycloheximide (CHX) was added. Cells were harvested at the indicated times to detect the level of viral protein by anti-Flag antibody. (D) Quantification of nsp16 protein levels relative to tubulin at different time points is shown. The half-life of the nsp16 protein was determined based on protein quantification using ImageJ, combined with the protein half-life formula for calculation. Results are shown as mean ± SD (n = 3 independent experiments). ***p<0.001 by a two-tailed t-test. ( E ) Samples were prepared for mass spectrometry, and nsp16 interacting proteins were obtained by immunoprecipitation (IP) (created with BioRender.com and the agreement no. is XR281XWMTN). The plasmids were transfected into HEK293T cells for 48 hr. Treat cells with or without MG132 (10 µM) for 12 hr prior to harvest. The whole-cell lysates were incubated with protein G agarose beads conjugated with anti-Flag antibodies and used for IB with anti-Flag antibodies to detect the nsp16 protein. Samples enriched for proteins were analyzed by mass spectrometry. Figure 1—source data 1. PDF file containing original western blots for , indicating the relevant bands and treatments. Figure 1—source data 2. Original files for western blot analysis displayed in . Figure 1—source data 3. Numerical data obtained during experiments represented in .
    Vinblastine, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/6-Mercaptopurine+(6-MP)+Monohydrate/pmc12074641-174-27-34
    Average 94 stars, based on 1 article reviews
    vinblastine - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress mp mce
    Figure 4. DNA-damaging drugs induce SIRT7-dependent MSH2 deacetylation and downregulation (A and B) SIRT7 and MSH2 colocalization in nucleoplasm under drug treatment. FLAG-SIRT7 and HA-MSH2 were cotransfected in HeLa cells in the presence or absence of 6-TG (10 mM) <t>or</t> <t>6-MP</t> (10 mM) treatment for 12 h. FLAG-SIRT7 was immunostained with anti-FLAG antibody (red), and HA-MSH2 was immunostained with anti-HA antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (A). HeLa cells were treated with 6-TG (10 mM) or 6-MP (10 mM) treatment for 12 h. SIRT7 was immunostained with anti-SIRT7 antibody (red), and MSH2 was immunostained with anti-MSH2 antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (B). (C) 293T cells were transfected with FLAG-SIRT7 and HA-MSH2 and treated with 6-TG (10 mM) for the indicated periods, followed by immunoprecipitation using anti-FLAG antibody and western blot with anti-HA antibody.
    Mp Mce, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mercaptopurine+6+mp/6-Mercaptopurine/pm39908142-477-182-183
    Average 94 stars, based on 1 article reviews
    mp mce - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) The nonstructural proteins nsp8, nsp11, and nsp16 could be restored by the proteasome inhibitor MG132. HEK293T cells in 12-well plates were transfected with the plasmids of 16 nonstructural proteins (nsp1–16) encoded by SARS-CoV-2. Thirty-six hours later, the cells were treated with MG132 (10 µM) or DMSO for 12 hr before collection. The protein level was detected by immunoblotting (IB). Quantification of nsp protein levels relative to the control protein is shown. Data are representative of three independent experiments and shown as average ± SD (n=3). Significance was determined by a two-tailed t-test: *p<0.05; **p<0.01; ***p<0.001. ( B ) Proteasomal inhibitors but no other inhibitors stabilized nsp16 protein. HEK293T cells transfected with the nsp16-Flag expression vector were treated with dimethyl sulfoxide (DMSO), MG132 (10 µM), Bortezomib (10 µM), Carfilzomib (10 µM), Bafilomycin A1 (5 µM), Vinblastine (2.5 µM), or NH 4 Cl (2.5 µM) for 12 hr prior to harvest. The cell lysates were analyzed by anti-Flag antibody. ( C, D ) The half-life of nsp16 was prolonged by the proteasome inhibitor MG132. (C) HEK293T cells were transfected with the nsp16-Flag-expressing plasmids. 12 hr later, the cells were treated with DMSO or MG132 (10 µM) for 12 hr, then 50 µg/ml cycloheximide (CHX) was added. Cells were harvested at the indicated times to detect the level of viral protein by anti-Flag antibody. (D) Quantification of nsp16 protein levels relative to tubulin at different time points is shown. The half-life of the nsp16 protein was determined based on protein quantification using ImageJ, combined with the protein half-life formula for calculation. Results are shown as mean ± SD (n = 3 independent experiments). ***p<0.001 by a two-tailed t-test. ( E ) Samples were prepared for mass spectrometry, and nsp16 interacting proteins were obtained by immunoprecipitation (IP) (created with BioRender.com and the agreement no. is XR281XWMTN). The plasmids were transfected into HEK293T cells for 48 hr. Treat cells with or without MG132 (10 µM) for 12 hr prior to harvest. The whole-cell lysates were incubated with protein G agarose beads conjugated with anti-Flag antibodies and used for IB with anti-Flag antibodies to detect the nsp16 protein. Samples enriched for proteins were analyzed by mass spectrometry. Figure 1—source data 1. PDF file containing original western blots for , indicating the relevant bands and treatments. Figure 1—source data 2. Original files for western blot analysis displayed in . Figure 1—source data 3. Numerical data obtained during experiments represented in .

    Journal: eLife

    Article Title: SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7

    doi: 10.7554/eLife.102277

    Figure Lengend Snippet: ( A ) The nonstructural proteins nsp8, nsp11, and nsp16 could be restored by the proteasome inhibitor MG132. HEK293T cells in 12-well plates were transfected with the plasmids of 16 nonstructural proteins (nsp1–16) encoded by SARS-CoV-2. Thirty-six hours later, the cells were treated with MG132 (10 µM) or DMSO for 12 hr before collection. The protein level was detected by immunoblotting (IB). Quantification of nsp protein levels relative to the control protein is shown. Data are representative of three independent experiments and shown as average ± SD (n=3). Significance was determined by a two-tailed t-test: *p<0.05; **p<0.01; ***p<0.001. ( B ) Proteasomal inhibitors but no other inhibitors stabilized nsp16 protein. HEK293T cells transfected with the nsp16-Flag expression vector were treated with dimethyl sulfoxide (DMSO), MG132 (10 µM), Bortezomib (10 µM), Carfilzomib (10 µM), Bafilomycin A1 (5 µM), Vinblastine (2.5 µM), or NH 4 Cl (2.5 µM) for 12 hr prior to harvest. The cell lysates were analyzed by anti-Flag antibody. ( C, D ) The half-life of nsp16 was prolonged by the proteasome inhibitor MG132. (C) HEK293T cells were transfected with the nsp16-Flag-expressing plasmids. 12 hr later, the cells were treated with DMSO or MG132 (10 µM) for 12 hr, then 50 µg/ml cycloheximide (CHX) was added. Cells were harvested at the indicated times to detect the level of viral protein by anti-Flag antibody. (D) Quantification of nsp16 protein levels relative to tubulin at different time points is shown. The half-life of the nsp16 protein was determined based on protein quantification using ImageJ, combined with the protein half-life formula for calculation. Results are shown as mean ± SD (n = 3 independent experiments). ***p<0.001 by a two-tailed t-test. ( E ) Samples were prepared for mass spectrometry, and nsp16 interacting proteins were obtained by immunoprecipitation (IP) (created with BioRender.com and the agreement no. is XR281XWMTN). The plasmids were transfected into HEK293T cells for 48 hr. Treat cells with or without MG132 (10 µM) for 12 hr prior to harvest. The whole-cell lysates were incubated with protein G agarose beads conjugated with anti-Flag antibodies and used for IB with anti-Flag antibodies to detect the nsp16 protein. Samples enriched for proteins were analyzed by mass spectrometry. Figure 1—source data 1. PDF file containing original western blots for , indicating the relevant bands and treatments. Figure 1—source data 2. Original files for western blot analysis displayed in . Figure 1—source data 3. Numerical data obtained during experiments represented in .

    Article Snippet: The drugs used in this study were as follows: MG132 (catalog no. S2619), Bafilomycin A1 (catalog no. S1413), Bortezomib (catalog no. S1013), Carfilzomib (catalog no. S2853), and Vinblastine (catalog no. S4504) were purchased from Selleck (Houston, TX, USA).

    Techniques: Transfection, Western Blot, Control, Two Tailed Test, Expressing, Plasmid Preparation, Mass Spectrometry, Immunoprecipitation, Incubation

    Figure 4. DNA-damaging drugs induce SIRT7-dependent MSH2 deacetylation and downregulation (A and B) SIRT7 and MSH2 colocalization in nucleoplasm under drug treatment. FLAG-SIRT7 and HA-MSH2 were cotransfected in HeLa cells in the presence or absence of 6-TG (10 mM) or 6-MP (10 mM) treatment for 12 h. FLAG-SIRT7 was immunostained with anti-FLAG antibody (red), and HA-MSH2 was immunostained with anti-HA antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (A). HeLa cells were treated with 6-TG (10 mM) or 6-MP (10 mM) treatment for 12 h. SIRT7 was immunostained with anti-SIRT7 antibody (red), and MSH2 was immunostained with anti-MSH2 antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (B). (C) 293T cells were transfected with FLAG-SIRT7 and HA-MSH2 and treated with 6-TG (10 mM) for the indicated periods, followed by immunoprecipitation using anti-FLAG antibody and western blot with anti-HA antibody.

    Journal: Cell reports

    Article Title: Phosphorylation of SIRT7 by ATM causes DNA mismatch repair downregulation and adaptive mutability during chemotherapy.

    doi: 10.1016/j.celrep.2025.115269

    Figure Lengend Snippet: Figure 4. DNA-damaging drugs induce SIRT7-dependent MSH2 deacetylation and downregulation (A and B) SIRT7 and MSH2 colocalization in nucleoplasm under drug treatment. FLAG-SIRT7 and HA-MSH2 were cotransfected in HeLa cells in the presence or absence of 6-TG (10 mM) or 6-MP (10 mM) treatment for 12 h. FLAG-SIRT7 was immunostained with anti-FLAG antibody (red), and HA-MSH2 was immunostained with anti-HA antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (A). HeLa cells were treated with 6-TG (10 mM) or 6-MP (10 mM) treatment for 12 h. SIRT7 was immunostained with anti-SIRT7 antibody (red), and MSH2 was immunostained with anti-MSH2 antibody (green) and visualized using fluorescence microscopy. Nuclei were stained with DAPI (scale bar, 10 mm) (B). (C) 293T cells were transfected with FLAG-SIRT7 and HA-MSH2 and treated with 6-TG (10 mM) for the indicated periods, followed by immunoprecipitation using anti-FLAG antibody and western blot with anti-HA antibody.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies ANTI-FLAG antibody Sigma-Aldrich Cat# F7425RRID: AB_439687 Monoclonal Anti-b-Actin Antibody Sigma-Aldrich Cat# A5441 RRID: AB_476744 GFP Antibody (15) Santa Cruz Biotechnology Cat# sc-101525 RRID: AB_1563142 SIRT7 Antibody Signalway Antibody Cat# 32106 RRID: AB_3674124 HA tag Polyclonal Antibody Proteintech Cat# 51064-2-AP RRID: AB_11042321 MLH1 Recombinant Antibody Proteintech Cat# 84208-2-RR RRID: AB_3671764 PMS2 Monoclonal antibody Proteintech Cat# 66075-1-Ig RRID: AB_11182595 GST Tag Monoclonal Antibody Proteintech Cat# 66001-2-Ig RRID: AB_2881488 6*His, His-tag Polyclonal Antibody Proteintech Cat# 10001-0-AP RRID: AB_11232228 Anti-MSH2 Antibody [3A2B8C] Abcam Cat# ab52266 RRID: AB_2144800 Anti-MSH6 Antibody [EPR3945] Abcam Cat# ab92471 RRID: AB_2144959 Phospho-(Ser/Thr) Phe Antibody CST Cat# 9631 RRID: AB_330308 Acetylated-Lysine Antibody CST Cat# 9441 RRID: AB_331805 Phospho-(Ser/Thr) ATM/ATR Substrate Antibody CST Cat# 2851 RRID: AB_330318 Bacterial and virus strains Trans1-T1 Phage Resistant Chemically Competent Cell TransGen Biotech CD501-2 Transetta(DE3) Chemically Competent Cell TransGen Biotech CD801-02 BL21(DE3) Chemically Competent Cell TransGen Biotech CD601-02 Biological samples Human Cervical Cancer Tissue Chip Shanghai Superbiotek Pharmaceutical Technology Co., Ltd CXC481 Human Lung Cancer Tissue Chip Shanghai Outdo Biotek Co., Ltd. HLug-Squ150Sur-02 Chemicals, peptides, and recombinant proteins 6-TG MCE Cat# HY-13765 6-MP MCE Cat# HY-13677 CPT MCE Cat# HY-16560 TMZ MCE Cat# HY-17364 MNNG MCE Cat# HY-128612 Etoposide MCE Cat# HY-13629 Mitomycin C MCE Cat# HY-13316 Cisplatin MCE Cat# HY-17394 Gemcitabine MCE Cat# HY-17026 MG132 Sigma-Aldrich Cat# M7449 (Continued on next page) Cell Reports 44, 115269, February 25, 2025 17

    Techniques: Microscopy, Staining, Transfection, Immunoprecipitation, Western Blot